| Literature DB >> 32292554 |
Zhili Xin1, Martin K Himmelbauer1, J Howard Jones1, Istvan Enyedy1, Rab Gilfillan1, Thomas Hesson1, Kristopher King1, Douglas J Marcotte1, Paramasivam Murugan1, Joseph C Santoro1, Felix Gonzalez-Lopez de Turiso1.
Abstract
Apoptosis signal-regulating kinase 1 (ASK1) is a key mediator in the apoptotic and inflammatory cellular stress response. To investigate the therapeutic value of modulating this pathway in neurological disease, we have completed medicinal chemistry studies to identify novel CNS-penetrant ASK1 inhibitors starting from peripherally restricted compounds reported in the literature. This effort led to the discovery of 21, a novel ASK1 inhibitor with good potency (cell IC50 = 138 nM), low clearance (rat Cl/Clu = 0.36/6.7 L h-1 kg-1) and good CNS penetration (rat K p,uu = 0.38).Entities:
Year: 2020 PMID: 32292554 PMCID: PMC7153032 DOI: 10.1021/acsmedchemlett.9b00611
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345